Viewing Study NCT01462318

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:47 AM
Ignite Modification Date: 2026-02-04 @ 12:16 PM
Study NCT ID: NCT01462318
Status: COMPLETED
Last Update Posted: 2017-03-14
First Post: 2011-07-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
Sponsor: Biogen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing-Remitting Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pre-filled syringe View
None Pharmacokinetic View
None Daclizumab High Yield Process View
None immunogenicity View